Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yves Lossouarn"'
Autor:
Tuan-Minh Do, Cécile Capdevila, Laurent Pradier, Véronique Blanchard, Mati Lopez-Grancha, Nathalie Schussler, Anke Steinmetz, Jochen Beninga, Denis Boulay, Philippe Dugay, Patrick Verdier, Nadine Aubin, Gihad Dargazanli, Catarina Chaves, Elisabeth Genet, Yves Lossouarn, Christophe Loux, François Michoux, Nicolas Moindrot, Franck Chanut, Thierry Gury, Stéphanie Eyquem, Delphine Valente, Olivier Bergis, Ercole Rao, Dominique Lesuisse
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 19, Iss , Pp 58-77 (2020)
Most antibodies display very low brain exposure due to the blood-brain barrier (BBB) preventing their entry into brain parenchyma. Transferrin receptor (TfR) has been used previously to ferry antibodies to the brain by using different formats of bisp
Externí odkaz:
https://doaj.org/article/83381acf39a84e849321af0a96b558c0
Autor:
Patrick Verdier, Stéphanie Eyquem, François Michoux, Véronique Blanchard, Dominique Lesuisse, Philippe Dugay, Thierry Gury, Olivier Bergis, Tuan Minh Do, Jochen Beninga, Nadine Aubin, Denis Boulay, Christophe Loux, Mati Lopez-Grancha, Catarina Chaves, Nicolas Moindrot, Delphine Valente, Cécile Capdevila, Nathalie Schussler, Ercole Rao, Gihad Dargazanli, Laurent Pradier, Yves Lossouarn, Franck Chanut, Elisabeth Genet, Anke Steinmetz
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 19, Iss, Pp 58-77 (2020)
Molecular Therapy: Methods & Clinical Development, Vol 19, Iss, Pp 58-77 (2020)
Most antibodies display very low brain exposure due to the blood-brain barrier (BBB) preventing their entry into brain parenchyma. Transferrin receptor (TfR) has been used previously to ferry antibodies to the brain by using different formats of bisp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::437d2cd5a3a8ad2ff6e07429b3b6c27f
https://pubmed.ncbi.nlm.nih.gov/33005703
https://pubmed.ncbi.nlm.nih.gov/33005703
Autor:
François Périn, Dominique Renault, Yves Lossouarn, Odette Perin-Roussel, Danièle Taras-Valéro, Dominique Brault, Véronique Thybaud
Publikováno v:
Carcinogenesis. 21(2)
5,9-Dimethyldibenzo[c,g]carbazole (DMDBC), a potent mouse hepatocarcinogen, has been shown to induce a non-linear increase in mutant frequency in the liver of the transgenic MutaMouse. To gain insight into the mechanisms underlying the mutagenicity o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3487e21d39aef6c25663b5cb1549db2
https://pubmed.ncbi.nlm.nih.gov/10657970
https://pubmed.ncbi.nlm.nih.gov/10657970